ChristineLKemptonMDMSc

Hematology • Atlanta, GA

Clotting Disorder, Hemophilia & Bleeding Disorder

Professor, Department of Hematology and Medical Oncology

Join to view full profile

Dr. Kempton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kempton's full profile

Already have an account?

Office
1365 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-778-1900

Education & Training

University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2001 - 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
Mayo Clinic College of MedicineClass of 1997

Certifications & Licensure

OR State Medical License 1998 - Present
GA State Medical License 2005 - 2025
NC State Medical License 2001 - 2005

Clinical Trials

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
Completed
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
Active, not recruiting
Phase 1, Phase 2
Enoxaparin Dosing in Obesity Start of enrollment: 2013 Mar 01
Completed
Phase 4

Publications & Presentations

PubMed

Assessment of joint health in females with haemophilia: The carriers ultrasound project (CUP) study.
Fernando F Corrales-Medina, Kelli Fraga, Maria D'Almeida Bastos, Amina Rafique, Christine L Kempton
Haemophilia. 2024-11-27
Women and girls' participation in haemophilia clinical trials.
Stacey A Fedewa, Lorraine Cafuir, Leonard A Valentino, Andee Koo, Ana Antun
Haemophilia. 2024-10-05
Is a Victim Mindset Perpetuating Burnout in Healthcare?
Christine L Kempton
The American Journal of Medicine. 2024-08-30

Journal Articles

Emicizumab Prophylaxis in Patients Who Have Hemophilia A Without Inhibitors
Christine Kempton, Gallia G Levy, Michael U Callaghan, The New England Journal of Medicine

Abstracts/Posters

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3
Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia _ Patients in the United States
Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Validation of Instrument to Assess Hemophilia-Related Distress
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hematologic Emergencies
2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
Hemophilia: A Disease in Transition
60th American Society of Hematology Annual Meeting - 12/2/2018

Authored Content

4 Ways I Fight BurnoutJune 2024

Press Mentions

Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding and Clotting Disorders Center at EmorySeptember 13th, 2018
ASH 2016 – Saturday, December 3December 3rd, 2015
Join now to see all